BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37938367)

  • 1. Unraveling intratumoral complexity in metastatic dermatofibrosarcoma protuberans through single-cell RNA sequencing analysis.
    Ge LL; Wang ZC; Wei CJ; Huang JX; Liu J; Gu YH; Wang W; Li QF
    Cancer Immunol Immunother; 2023 Dec; 72(12):4415-4429. PubMed ID: 37938367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unforeseen clonal evolution of tumor cell population in recurrent and metastatic dermatofibrosarcoma protuberans.
    Oh E; Jeong HM; Kwon MJ; Ha SY; Park HK; Song JY; Kim YJ; Choi JS; Lee EH; Lee J; Choi YL; Shin YK
    PLoS One; 2017; 12(10):e0185826. PubMed ID: 28977029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatofibrosarcoma protuberans metastasizing to lymph nodes: a case report and review of literature.
    Lal P; Sharma R; Mohan H; Sekhon MS
    J Surg Oncol; 1999 Nov; 72(3):178-80. PubMed ID: 10562366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic alterations of dermatofibrosarcoma protuberans revealed by whole-genome sequencing.
    Peng C; Jian X; Xie Y; Li L; Ouyang J; Tang L; Zhang X; Su J; Zhao S; Liu H; Yin M; Wu D; Wan M; Xie L; Chen X
    Br J Dermatol; 2022 Jun; 186(6):997-1009. PubMed ID: 35441365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatofibrosarcoma protuberans, version 1.2014.
    Bichakjian CK; Olencki T; Alam M; Andersen JS; Berg D; Bowen GM; Cheney RT; Daniels GA; Glass LF; Grekin RC; Grossman K; Ho AL; Lewis KD; Lydiatt DD; Morrison WH; Nehal KS; Nelson KC; Nghiem P; Perlis CS; Shaha AR; Thorstad WL; Tuli M; Urist MM; Wang TS; Werchniak AE; Wong SL; Zic JA; McMillian N; Hoffman K; Ho M
    J Natl Compr Canc Netw; 2014 Jun; 12(6):863-8. PubMed ID: 24925197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.
    Patel KU; Szabo SS; Hernandez VS; Prieto VG; Abruzzo LV; Lazar AJ; López-Terrada D
    Hum Pathol; 2008 Feb; 39(2):184-93. PubMed ID: 17950782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of Dermatofibrosarcoma Protuberans to DFSP-Derived Fibrosarcoma: An Event Marked by Epithelial-Mesenchymal Transition-like Process and 22q Loss.
    Stacchiotti S; Astolfi A; Gronchi A; Fontana A; Pantaleo MA; Negri T; Brenca M; Tazzari M; Urbini M; Indio V; Colombo C; Radaelli S; Brich S; Dei Tos AP; Casali PG; Castelli C; Dagrada GP; Pilotti S; Maestro R
    Mol Cancer Res; 2016 Sep; 14(9):820-9. PubMed ID: 27256159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Morphea to Dermatofibrosarcoma Protuberans.
    Crnarić I; Šitum M; Delaš Aždajić M; Vučić M; Buljan M
    Acta Dermatovenerol Croat; 2022 Sep; 30(2):113-115. PubMed ID: 36254545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic potential of dermatofibrosarcoma protuberans with fibrosarcomatous change.
    Minter RM; Reith JD; Hochwald SN
    J Surg Oncol; 2003 Mar; 82(3):201-8. PubMed ID: 12619065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatofibrosarcoma protuberans: Clinicopathological spectrum with emphasis on lymph node metastasis and fibrosarcomatous transformation.
    Dahiya S; Tomar R; Ahuja M; Mallya V; Mandal S; Khurana N; Rathi AK
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S439-S443. PubMed ID: 36511000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel TNC-PDGFD fusion in fibrosarcomatous dermatofibrosarcoma protuberans: a case report.
    Chen Y; Shi YZ; Feng XH; Wang XT; He XL; Zhao M
    Diagn Pathol; 2021 Jul; 16(1):63. PubMed ID: 34256767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COL1A1-PDGFB Fusion Gene Detection Through Bulk RNA-Seq and Transcriptomic Features of Dermatofibrosarcoma Protuberans.
    Peng R; Zhang G; Li H
    Dermatol Surg; 2023 May; 49(5S):S27-S33. PubMed ID: 37115997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans.
    Linn SC; West RB; Pollack JR; Zhu S; Hernandez-Boussard T; Nielsen TO; Rubin BP; Patel R; Goldblum JR; Siegmund D; Botstein D; Brown PO; Gilks CB; van de Rijn M
    Am J Pathol; 2003 Dec; 163(6):2383-95. PubMed ID: 14633610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
    Hisaoka M; Okamoto S; Morimitsu Y; Tsuji S; Hashimoto H
    Virchows Arch; 1998 Oct; 433(4):323-9. PubMed ID: 9808434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatofibrosarcoma protuberans: recent clinical progress.
    McArthur G
    Ann Surg Oncol; 2007 Oct; 14(10):2876-86. PubMed ID: 17647063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite instability and p53 mutation associated with tumor progression in dermatofibrosarcoma protuberans.
    Takahira T; Oda Y; Tamiya S; Yamamoto H; Kawaguchi K; Kobayashi C; Oda S; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2004 Feb; 35(2):240-5. PubMed ID: 14991543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine-needle aspiration of dermatofibrosarcoma protuberans metastasizing to hemithorax with superior vena cava compression: Case report and literature review.
    Banach BS; Antic T; Bridge JA; Cipriani NA; Frye L; Krausz TN; Biernacka A
    Diagn Cytopathol; 2019 Aug; 47(8):797-802. PubMed ID: 30919592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusual clinical presentation of myxoid dermatofibrosarcoma protuberans with a prominent vasculature: A potential pitfall in the diagnosis of myxoid soft tissue tumors.
    Tran P; Henderson GP; McLemore M
    J Cutan Pathol; 2018 Jun; 45(6):419-422. PubMed ID: 29468850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation.
    Rutkowski P; Klimczak A; Ługowska I; Jagielska B; Wągrodzki M; Dębiec-Rychter M; Pieńkowska-Grela B; Świtaj T
    Eur J Surg Oncol; 2017 Jun; 43(6):1134-1141. PubMed ID: 28365129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic dermatofibrosarcoma protuberans of the vulva.
    Soergel TM; Doering DL; O'connor D
    Gynecol Oncol; 1998 Nov; 71(2):320-4. PubMed ID: 9826480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.